慢性乙型肝炎抗病毒治疗期间低酸血的临床后果
Mee Yeon Park1, Hojin Jeon1, Kyungho Park1
1Division of Nephrology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
低血症是慢性乙型肝炎 (CHB) 抗病毒疗法的副作用,与功能下降有关. 这项研究澄清了这种不良影响在CHB患者中的临床意义.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗病毒治疗对于治疗慢性乙型肝炎 (CHB) 至关重要.
- 低酸血是抗病毒药物的已知不良影响,但其临床影响尚未明确.
- 本研究研究了CHB患者中低酸血症的发生率和后果.
研究的目的:
- 在接受抗病毒治疗的慢性乙型肝炎患者中调查低酸血的发生率.
- 确定低血的临床后果,重点关注功能和其他生化标志物.
主要方法:
- 在2005年至2015年期间接受治疗的4,335名CHB患者的回顾性队列研究.
- 排除标准包括不补偿性肝硬化,糖尿病,高血压,利尿剂使用和末期病.
- 主要结局:功能变化;次要结局:感染发病率,血清,尿酸和tCO2水平.
主要成果:
- 低酸盐血症发生在队列中的1.7% (75名患者) 中.
- 患有低脂血症的患者在中位数2年的随访期间,估计的淋巴细胞过率 (eGFR) 较低.
- 两组之间没有观察到感染率或血清,尿酸或tCO2变化的显著差异.
结论:
- 低脂血症与接受抗病毒治疗的CHB患者的功能受损有关.
- 这些发现强调了监测CHB患者患有低酸血症的功能的重要性.
- 进一步的研究可能会阐明将低酸血症与此种人群中的衰退联系在一起的机制.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Retrovirus Life Cycles
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
